NCT06647134招募中不适用
A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 20
- 试验地点
- 1
- 主要终点
- Safety and Adverse Events (AEs).
研究概览
简要总结
To understand the severity and nature of participants experiences during irAEs following immune checkpoint inhibitor immunotherapy.
详细描述
- To understand the severity and nature of participants experiences during rheumatic immune-related adverse events following immune checkpoint inhibitor immunotherapy, including their functional impact
- To explore domains relevant to participants experiencing rheumatic immune-related adverse events following immune checkpoint inhibitor immunotherapy, and attitudes to domains identified from the literature
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •The criteria are:
- •Patients aged 18 years and above
- •English (conversational level) speaking, with the ability to give informed consent
- •Patients with a rheumatologist clinician diagnosis of inflammatory arthritis irAE or PMR irAE following ICI therapy
排除标准
- •Acutely life-threatening or worsening cancer
- •Hearing impairment functionally limiting participation in verbal interview
结局指标
主要结局
Safety and Adverse Events (AEs).
时间窗: Through study completion; an average of 1 year
Incidence of Adverse Events
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Side Effects of Anti-PD-(L)-1 and Anti CTLA-A4 in the Non Small Cells Lung CancerCarcinoma, Non-Small-Cell LungDrug-Related Side Effects and Adverse ReactionsNCT03125603Cliniques universitaires Saint-Luc- Université Catholique de Louvain80
尚未招募
不适用
Gene Compatibility and Outcomes of Paediatric and Adolescent Patients of Parental Donor Kidney TransplantsACTRN12620000911998niversity of Western Australia550
招募中
不适用
IMMunological resPonse Assessment afteR Acute iSchemic Stroke Treated With Endovascular Therapy (IMPRESS)Ischemic StrokeThrombectomyNCT04663399Fondation Ophtalmologique Adolphe de Rothschild1,200
Unknown
不适用
SYSTEMATIC SYMPTOM ASSESSMENT IN CANCER PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORSLung CancerMelanomaNCT04929353University Of Perugia280
已完成
不适用
Evaluation of Reporting of Immune Checkpoint Inhibitor Associated Cardio-vascular Adverse ReactionsCardiac ComplicationMyocarditisNCT03387540Groupe Hospitalier Pitie-Salpetriere104